An overview of tenofovir and renal disease for the HIV-treating clinician

Willem D.F. Venter; June Fabian; Charles Feldman

Crossref Citations

1. Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa
Rephaim Mpofu, Aida N. Kawuma, Roeland E. Wasmann, Godspower Akpomiemie, Nomathemba Chandiwana, Simiso Mandisa Sokhela, Michelle Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A. Post, David W. Haas, Gary Maartens, Phumla Sinxadi
British Journal of Clinical Pharmacology year: 2024
doi: 10.1111/bcp.16009

African Online Scientific Information Systems (Pty) Ltd t/a AOSIS
Reg No: 2002/002017/07
International Tel: +27 21 975 2602
5 Hafele Street, Durbanville, Cape Town, 7550, South Africa
publishing(AT)aosis.co.za replace (AT) with @

All articles published in this journal are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, unless otherwise stated.
Website design & content: ©2024 AOSIS (Pty) Ltd. All rights reserved. No unauthorised duplication allowed.
By continuing to use this website, you agree to our Privacy Policy, Terms of Use and Security Policy.

________

Subscribe to our newsletter

Get specific, domain-collection newsletters detailing the latest CPD courses, scholarly research and call-for-papers in your field.

Southern African Journal of HIV Medicine | ISSN: 1608-9693 (PRINT) | ISSN: 2078-6751 (ONLINE)